XTEK Ltd directors support expansion strategy with on-market purchases
XTEK directors support expansion strategy with on-market purchases The company recently signed an agreement to exclusively distribute and support Virolens in Australia and New Zealand and late last year secured a $1 million contract for the next phase of the C4 EDGE Program for the Australian Army. Uwe Boettcher now holds a total of 5,740,408 shares in the company and Chris Fullerton holds 200,000. XTEK Ltd (ASX:XTE) directors have displayed confidence in the company’s growth strategy through on-market share purchases. Non-executive director and chairman Uwe Boettcher has today...
Source: proactiveinvestors.com.au